Here’s the CSL dividend forecast through to 2025

If you’re a shareholder of biotherapeutics giant CSL Limited (ASX: CSL), you may be wondering where its dividend is heading in the coming years.

Especially now that its outlook has improved greatly following a recovery in plasma collections, strong demand for immunoglobulins, and its acquisition of Vifor Pharma.

Let’s take a look to see what analysts are forecasting for the CSL dividend.

Where is the CSL dividend heading through to 2025?

Firstly, let’s start with the current CSL dividend. Last week the company released its full year results and declared a partially franked US$1.18 (A$1.68) per share final dividend.

This meant the company’s full year dividend was flat year over year at US$2.22 (A$3.11) per share.

Looking ahead, according to a note out of Goldman Sachs, its analysts are expecting the company’s dividend to return to growth again in FY 2023. Its analysts have pencilled in a US$2.52 (A$3.66) per share dividend. This represents a 13.5% increase over FY 2022’s payout. And with the CSL share price currently fetching $288.63, this will mean a modest yield of 1.3%.

In FY 2024, Goldman expects another increase to the CSL dividend. It is forecasting a dividend of US$3.21 (A$4.66) per share for this financial year. This will be a 27% increase and represents a 1.6% yield at today’s prices.

Finally, the following year in FY 2025, the broker is expecting another increase. It is estimating a US$3.47 (A$5.04) per share dividend that year. This is an increase of 8.1% and equates to a yield of 1.75%.

While these are admittedly not the biggest yields you’ll find today, if CSL carries on this trend over the next decade and beyond, they could grow to be very attractive for income investors in the future.

The post Here’s the CSL dividend forecast through to 2025 appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• How have ASX dividend shares been performing this earnings season?
• The ASX had its worst day in 6 weeks, but the CSL share price gained. Why?
• Is the CSL share price in the buy zone?
• Why I would invest $10,000 into these ASX shares for 10 years
• Brokers name 3 ASX shares to buy today

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/WP2aSGU